Logo

Cosmo Bio Distributing SwitchGear System in Japan

Jun 30, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SwitchGear Genomics today announced that Cosmo Bio will distribute its products in Japan.

Under the deal, Cosmo Bio will distribute the LightSwitch Luciferase Assay System with marketing and technical support from SwitchGear. The system comprises a complete reporter assay solution that includes a genome-wide collection of human promoter and 3' UTR luciferase reporters and optimized luciferase assay reagents for measuring transcriptional activation and translational efficiency in living cells.

In February, Menlo Park, Calif.-based SwitchGear announced a deal with BioCat for distribution of the system in Germany, Austria, and Switzerland.

Financial and other terms of the deal were not disclosed.

Based in Tokyo, Cosmo supplies research instruments and reagents to the life science community in Japan.

Filed under

Cell Biology Research
Business News
distribution agreement
cell-based assays
SwitchGear Genomics
Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.